Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03016819
Brief Title: A Phase III Trial of Anlotinib in Metastatic or Advanced Alveolar Soft Part Sarcoma, Leiomyosarcoma and Synovial Sarcoma (APROMISS)

First Submitted : January 6, 2017
First Submitted that Met QC Criteria : January 9, 2017
First Posted : January 11, 2017 (Estimate)

Last Update Submitted that Met QC Criteria : September 20, 2019
Last Update Posted : September 24, 2019